We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The pharmaceutical industry has engaged in record-breaking spending on lobbying efforts in the first quarter of 2021, according to a nonpartisan lobbying research group, as Democrats continue their push for passage of drug pricing measures. Read More
Eli Lilly has partnered with UK-based MiNA Therapeutics to develop treatments using small activating RNA (saRNA) technology, a new class of drugs pioneered by MiNA. Read More
Amplyx’s Fosmanogepix is being evaluated in ongoing phase 2 trials in both intravenous and oral formulations for treatment of life-threatening fungal infections. Read More
Deliveries of the J&J vaccine, which were recently paused as the European Medicines Agency investigated the risk of blood clots, are now resuming in Europe with a blood clot warning added to the product information. Read More
AstraZeneca (AZ) reportedly may not file for FDA Emergency Use Authorization (EUA) of its COVID-19 vaccine until mid-May as it needs more time to gather supporting data. Read More